Pharma Stocks Outlook for the week (25-29.06.2012)

[rupeedesk]

Pharma Stocks Outlook for the week (25-29.06.2012)

Pharmaceutical stocks are seen trading in a range with a positive bias next week. The domestic pharmaceutical market continues to track strong growth trajectory with 16% growth (in sales) in May 2012. Growth break-up over the past 12 months indicates volume growth of 8.6%, new products growth of 4% and price growth of 3.6%. As the broad market is largely seen volatile during the coming week, pharmaceutical stocks, being defensive in nature, are going to be a safe haven for investors.

Trade in the broad market is seen volatile next week ahead of the expiry of the June futures contract on Thursday. Stocks movement would depend on the kind of rollovers the pharmaceutical counters see. A long rollover would indicate investors still expect stocks to gain in the medium- to long-term while a short rollover shows people do not expect stocks to gain much in the coming months. The sector is also awaiting an Inter Ministerial Group's final decision on allowing foreign direct investment in pharmaceutical Brownfield projects. Pharmaceutical companies' stocks are likely to take cue from the outcome of the panel's meeting Tuesday. Cadila Healthcare is likely to see a further rise next week as the US Food and Drug Administration's approval to the company's Gujarat plant is seen coming in shortly.